CUREDM GROUP HOLDINGS LLC has a total of 24 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and New Zealand. Its main competitors in its focus markets pharmaceuticals and biotechnology are SERPIN PHARMA LLC, GEMMA BIOTECHNOLOGY LTD and NEURONAX.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | New Zealand | 3 | |
#4 | Israel | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Hong Kong | 1 | |
#8 | Mexico | 1 | |
#9 | Malaysia | 1 | |
#10 | Singapore | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Levetan Claresa S | 21 |
#2 | Garsky Victor M | 10 |
#3 | Upham Loraine V | 9 |
#4 | Upham Loraine Veal | 2 |
#5 | Levetan Calresa S | 1 |
Publication | Filing date | Title |
---|---|---|
AU2008292913A1 | Compositions and methods of using proislet peptides and analogs thereof | |
CA2726759A1 | Human proislet peptide, derivatives and analogs thereof, and methods of using same |